Investors & media




INVESTOR INFORMATION: KEY FACTS




Stock Market NYSE Euronext Paris - Eurolist (compartment B)
Reuters /Bloomberg TRNG.PA / TNG.FP
ISIN Code FR0005175080
Total number of shares outstanding 38 444 106
First Quote on Nouveau Marché & Nasdaq* 26 March 1998
Local Sector Index Next Biotech / CAC Mid 100
Financial Year Ends December 31

 

 


Funding History

 

Date Operation Capital Raised
March 2014
Rights Offering & Private Placement
€65.5 million
June   2010
Capital Increase
€152.0 million
June   2007
Capital Increase
€100.1 million
July    2006
Capital Increase/Warrants Exercised
€14.3 million
June   2005 Capital Increase on Euronext Paris
€34.9 million
May    2001
Follow-on Nouveau Marché & Nasdaq
€63.1 million
March 1998
IPO Nouveau Marché & Nasdaq* US$100 million

*De-listed from Nasdaq 23 September, 2005



Shareholding Structure

 

52 % Institut Merieux
23 % Institutional Investors
18 % Retail Investors
7 % Others

 



Key Financial Highlights (€ Million)

 

Year Cash Burn (net) R&D expenses

Cash & cash equivalents

2013 45.0 50.1 47.9
2012 46.6 48.7 92.9
2011 39.6(2) 53.0 139.5
2010 28.8(1) 42.5 180.3
2009 22.0 33.0 64.7

(2) Excluding investment in Jennerex Inc.

(1) Excluding capital increase and investment in Jennerex Inc.